NASH Explored - Emerging Concepts in Nonalcoholic Steatohepatitis
Nov
12
2023
Product Theater 1, Exhibit Hall B
-
Hynes Convention Center
10:15
- 11:00 AM EST
Description
Supported by: Madrigal Pharmaceuticals
This session will explore several emerging concepts in NASH including: (1) epidemiology and comorbidities, (2) pathophysiology and the role of lipotoxicity in the liver, (3) morbidity and mortality, (4) patient identification and monitoring approaches, and (5) disease management strategies.
Presenters:
Stephen A. Harrison, M.D., COL (ret.)
Naim Alkhouri, MD, FAASLD